Galileo - Biotech Innovation Fund BC Fonds
56,01
USD
-0,60
USD
-1,06
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Arcellx Inc | US03940C1009 | 8,96% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 7,42% |
| Krystal Biotech Inc | US5011471027 | 7,31% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,32% |
| BioNTech SE ADR | US09075V1026 | 5,06% |
| Stoke Therapeutics Inc | US86150R1077 | 4,61% |
| CARsgen Therapeutics Holdings Ltd Ordinary Shares | KYG1996C1006 | 3,61% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,59% |
| Gilead Sciences Inc | US3755581036 | 3,39% |
| CRISPR Therapeutics AG | CH0334081137 | 2,94% |
| Sonstige | 47,80% |